XML 33 R24.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2022
Stock-Based Compensation  
Schedule of stock-based compensation expense

Stock-based compensation expense as reflected in the Company’s condensed consolidated statements of operations and comprehensive loss was as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended June 30, 

​

Six months ended June 30, 

​

    

2022

    

2021

​

2022

    

2021

Research and development

​

$

191

​

$

47

​

$

274

​

$

74

General and administrative

​

 

646

​

 

111

​

 

1,190

​

 

149

Stock-based compensation expense included in operating expenses

​

$

837

​

$

158

​

$

1,464

​

$

223

Summary of stock option activity

The following is a summary of the Company’s stock option activity for the six months ended June 30, 2022:

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

Weighted- 

    

Weighted- average 

    

Aggregate 

​

​

​

​

average 

​

remaining contractual 

​

intrinsic value

​

​

Options

​

exercise price

​

term (in years)

​

(in thousands)

Outstanding at December 31, 2021

 

3,021,799

​

$

3.71

 

8.94

​

$

10,903

Granted

 

1,436,995

​

 

3.32

 

​

​

 

​

Exercised

​

(44,105)

​

​

0.43

​

​

​

​

​

Cancelled

​

(232,987)

​

​

4.24

​

​

​

​

​

Outstanding at June 30, 2022

 

4,181,702

​

 

3.58

 

9.07

​

$

697

Vested at June 30, 2022

 

1,097,333

​

 

2.53

 

8.65

​

$

435

Vested and expected to vest at June 30, 2022

 

4,181,702

​

$

3.58

 

9.07

​

$

697

​

The following is a summary of the Company’s stock option activity for the six months ended June 30, 2021:

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

Weighted- 

    

Weighted- average 

    

Aggregate 

​

​

​

​

average 

​

remaining contractual 

​

intrinsic value

​

​

Options

​

exercise price

​

term ( in years)

​

(in thousands)

Outstanding at December 31, 2020

 

1,761,062

​

$

0.95

 

9.54

​

$

723

Granted

 

1,016,337

​

 

7.84

 

—

​

 

8,292

Outstanding at June 30, 2021

 

2,777,399

​

 

3.47

 

9.36

​

$

34,797

Vested at June 30, 2021

 

337,190

​

 

0.49

 

8.49

​

$

5,217

Vested and expected to vest at June 30, 2021

 

2,777,399

​

$

3.47

 

9.36

​

$

34,797

Schedule of assumptions used in estimation of fair value

The weighted average grant-date fair value of stock options granted during the six months ended June 30, 2022 and 2021 was $2.22 and $5.17 per share, respectively. The fair value of each stock option was estimated using a Black-Scholes option-pricing model with the following assumptions:

​

​

​

​

​

​

​

​

​

​

​

​

    

Three months ended June 30, 

 

​

Six months ended June 30, 

 

​

​

2022

    

2021

 

​

2022

    

2021

 

Risk-free interest rate

 

2.84 - 3.34

%  

0.96 - 1.09

%

​

1.62 - 3.34

%  

0.95 - 1.09

%

Volatility

 

75 - 80

%  

77

%

​

75 - 80

%  

77

%

Dividend yield

 

0.00

%  

0.00

%

​

0.00

%  

0.00

%

Expected term (years)

 

6

 

6

​

​

6

 

6

​

Summary of restricted stock units activity

The following table summarizes activity related to restricted stock units:

​

​

​

​

​

​

​

    

​

    

Weighted- average

​

​

​

​

grant date

​

​

Number of shares

​

fair value

Unvested at December 31, 2021

 

200,996

​

$

16.00

Granted

 

—

​

 

—

Vested

​

(50,249)

​

​

​

Unvested at June 30, 2022

 

150,747

​

$

16.00